Top

Published in:

01-04-2023 | Dapagliflozin | Clinical study

High-dose dapagliflozin increases risk of UTI

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Treatment with high-dose dapagliflozin in patients with type 2 diabetes mellitus (T2DM) increases the risk of urinary tract infection (UTI). This was one of the findings of a systematic review and meta-analysis published in Clinical Drug Investigation . …

Risk of Urinary Tract Infection in Patients with Type 2 Diabetes Mellitus Treated with Dapagliflozin: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Clinical Drug Investigation 43: 209-225, et al. Apr 2023. Available from: URL: https://doi.org/10.1007/s40261-023-01256-9

Title: High-dose dapagliflozin increases risk of UTI
Publication date: 01-04-2023
Publisher: Springer International Publishing
Keywords: Dapagliflozin
Urinary Tract Infection
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-37441-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

High-dose dapagliflozin increases risk of UTI

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Ciclosporin/ganciclovir/mycophenolate-mofetil

Antineoplastics

Nivolumab

Antineoplastics

Enoxaparin-sodium

Adalimumab/etanercept/secukinumab